Can nafamostat mesilate be used for temporary management of hemodialysis in a patient with heparin-induced thrombocytopenia (HIT)?

Thrombosis and Haemostasis

Volumn 86, Issue 4, 2001, Pages 1115-1116

  Matsuo, T ^a   Matsuo, M ^a   Ouga Maruyama, S ^a  

^a HYOGO PREFECTURAL AWAJI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA THROMBOGLOBULIN; D DIMER; HEPARIN; NAFAMSTAT MESILATE; THROMBOCYTE FACTOR 4;

ADULT; ANTIBODY TITER; ANTICOAGULATION; BLOOD CLOTTING; CASE REPORT; DRUG EFFECT; EXTRACORPOREAL CIRCULATION; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; LETTER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UREMIA;

EID: 0034761518     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616542     Document Type: Letter

References (10)

1. Nafamostat mesilate: A regional anticoagulant for hemodialysis in platelets at high risk for bleeding
2. The influence of a serine protease inhibitor, nafamostat mesilate, on plasma coagulation, and platelet activation during experimental extracorporeal life support (ECLA)
3. Nafamostat mesilate, a broad spectrum protease inhibitor, modulates platelets, neutrophil and contact activation in simulated extracorporeal circulation
4. The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia
5. Aspirin prevents heparin-induced platelet aggregation in vivo
6. Effect of aspirin on heparin-induced thrombocytopenia (HIT) in a patient requiring hemodialysis
7. Fibrin D-dimer in thrombogenic disorders
8. Amidinonaphthol derivatives directly inhibit the ligand binding on platelet glycoprotein IIb-IIIa
9. Successful use of low dose r-hirudin (Refludan) for recurrent dialysis catheter thrombosis in a patient with heparin induced thrombocytopenia
10. Transience of heparin-induced thrombocytopenia antibodies